Moore Capital Management’s Surgery Partners SGRY Stock Holding History

Moore Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$840K	Hold	50,000	–	–	0.01%	502
2026 Q1	$596K	Hold	50,000	–	–	0.01%	407
2025 Q4	$773K	Hold	50,000	–	–	0.01%	476
2025 Q3	$1.08M	Sell	50,000 -50,000	-50%	-$1.12M	0.01%	408
2025 Q2	$2.22M	Buy	100,000 +30,000	+43%	+$667K	0.03%	311
2025 Q1	$1.66M	Buy	70,000 +20,000	+40%	+$473K	0.03%	280
2024 Q4	$1.06M	Hold	50,000	–	–	0.01%	369
2024 Q3	$1.61M	Sell	50,000 -25,000	-33%	-$738K	0.03%	324
2024 Q2	$1.78M	Hold	75,000	–	–	0.03%	280
2024 Q1	$2.24M	Buy	75,000 +25,000	+50%	+$782K	0.04%	259
2023 Q4	$1.6M	Buy	+50,000	New	+$1.45M	0.03%	244

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Moore Capital Management's SGRY Position: Q2 2026 in Review

Moore Capital Management held its Surgery Partners (SGRY) position steady in Q2 2026 at 50,000 shares worth $840K. The position accounts for 0.01% of the portfolio, ranked #502.

Moore Capital Management first reported a position in SGRY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.24M in Q1 2024. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

Moore Capital Management held 50,000 shares of Surgery Partners worth $840K as of Q2 2026.
Moore Capital Management left its Surgery Partners share count unchanged in Q2 2026.
Surgery Partners made up 0.01% of Moore Capital Management's portfolio in Q2 2026, its #502 holding.
Moore Capital Management first reported a position in Surgery Partners in Q4 2023 and has held it in 11 quarters since.
Moore Capital Management's Surgery Partners position peaked at $2.24M in Q1 2024.
187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.